Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125415071 | 12541507 | 1 | I | 20160701 | 20160708 | 20160708 | EXP | US-AMGEN-USASL2016086667 | AMGEN | 74.00 | YR | E | F | Y | 0.00000 | 20160708 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125415071 | 12541507 | 1 | PS | PROLIA | DENOSUMAB | 1 | Unknown | UNK | U | 125320 | SOLUTION FOR INJECTION | ||||||||
125415071 | 12541507 | 2 | C | TIMOLOL. | TIMOLOL | 1 | 0 | ||||||||||||
125415071 | 12541507 | 3 | C | XALATAN | LATANOPROST | 1 | 0 | ||||||||||||
125415071 | 12541507 | 4 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125415071 | 12541507 | 1 | Osteoporosis postmenopausal |
125415071 | 12541507 | 2 | Glaucoma |
125415071 | 12541507 | 3 | Glaucoma |
125415071 | 12541507 | 4 | Thyroid disorder |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125415071 | 12541507 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125415071 | 12541507 | Neuropathy peripheral | |
125415071 | 12541507 | Tooth disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125415071 | 12541507 | 1 | 2012 | 0 |